Sign in

NCT06444360Recruiting

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Adolescents and Young Adults (Project IMPACT)

Source: ClinicalTrials.gov · Last updated 2 Nov 2026

Brief summary (registry, in English)

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
360 (estimated)
First submitted
30 May 2024
Start date
4 Nov 2025
Primary completion date
30 Jun 2029
Lead sponsor
Westat
Diseases
HIV
NCT number
NCT06444360

What you commit to

  • Study type: Interventional
  • Planned participants: 360
  • From 4 Nov 2025 to the primary completion date, 30 Jun 2029
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
  • Randomized to IMPACT arm of study prior to March 2025 study pause

Other illness

  • Unable to provide informed consent due to severe mental or physical illness
  • Any other medical condition, medical/behavioral intervention, or other condition that, in the opinion of the Project Lead or designee, could interfere with the safety of participants or staff, adherence to study procedures, or compromise interpretation of study results

Other

  • Non-English-speaking
  • Is currently incarcerated or pending incarceration
  • Is currently pregnant or planning to become pregnant

Who the study is looking for

  • Age 16-24 years, inclusive, at enrollment
  • Self-reports condomless sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)
  • Willing and able to provide written informed consent for study participation
  • Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)
  • Provide a mailing address where they can receive a package
  • Access to stable internet that they can use for more than 2 hours at a time
  • Have a private place (where no one else can see or hear) where they can complete visits online
  • Reside within the continental U.S.

Age in the registry: 16 years to 24 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
Brown University
Coordinator of this site? Confirm its status
ProvidenceUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.